Gemmothérapie d'Aubepine
Food supplement declared in France, declaration No 2023-4-427, decision dated 12 April 2023
Gemmothérapie d'Aubepine (Disamare) is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). None of the rules we check flags an issue with its declared composition.
- Brand
- Disamare
- Food business operator placing the product on the market
- Giulia Ciaghi
- Status
- Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
- Form
- Compte-gouttes
- Daily dose
- 0,75 ml
- Not recommended for (according to the manufacturer)
- Femmes allaitantes, Femmes enceintes, Enfants (de moins de 10 ans)
Declaration 193382, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.
Regulatory points
None of the rules we check applies to the declared ingredients.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Crataegus monogyna Jacq. | Feuille (bourgeon) | Autre macérât | 0.75 ml |
Other active ingredients
| Name | Per day |
|---|---|
| miel | not declared |
Other ingredients
Alcool, Eau potable
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Crataegus monogyna Jacq.
Read the warning, when it applies and the studies cited
Hawthorn
Route of administration: Oral (ESCOP 2009; Bradley 2006; Mills and Bone 2000)
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking cardiac glycosides (e.g., digoxin) or blood pressure or heart medications (Brinker 2010; Bradley 2006).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have chest pain, irregular heartbeat, or shortness of breath.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
Brand : Disamare
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.